These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14982879)

  • 1. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.
    Studt JD; Kremer Hovinga JA; Radonic R; Gasparovic V; Ivanovic D; Merkler M; Wirthmueller U; Dahinden C; Furlan M; Lämmle B
    Blood; 2004 Jun; 103(11):4195-7. PubMed ID: 14982879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin.
    Studt JD; Kremer Hovinga JA; Antoine G; Hermann M; Rieger M; Scheiflinger F; Lämmle B
    Blood; 2005 Jan; 105(2):542-4. PubMed ID: 15367436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
    Thomas MR; de Groot R; Scully MA; Crawley JT
    EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K; Miyata T
    Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga J; Studt JD; Mansouri Taleghani B; Alberio L
    Hematol J; 2004; 5 Suppl 3():S6-11. PubMed ID: 15190269
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
    Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
    PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
    Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
    Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
    Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.
    Scheiflinger F; Knöbl P; Trattner B; Plaimauer B; Mohr G; Dockal M; Dorner F; Rieger M
    Blood; 2003 Nov; 102(9):3241-3. PubMed ID: 12855569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial acquired thrombotic thrombocytopenic purpura in siblings - no immunogenetic link with associated human leucocyte antigens.
    Gödel P; Fischer J; Scheid C; Gathof BS; Wolf J; Rybniker J
    Eur J Haematol; 2017 Mar; 98(3):311-313. PubMed ID: 27859681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
    Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of ADAMTS13 activity and inhibitors.
    Miyata T; Kokame K; Banno F
    Curr Opin Hematol; 2005 Sep; 12(5):384-9. PubMed ID: 16093784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 20. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.